Notes From the Incoming Editor
Last month in this column, we introduced a number of new initiatives that will be featured in Circulation starting in July of this year.1 These include a section called Frame of Reference, which will host a range of content, including opinion pieces (On My Mind), thoughtful, evidence-based treatments of a given topic (Perspective), Point/Counterpoint, and Clinical Implications of Basic Research.
Paths to Discovery
The final component of the Frame of Reference Section will be titled Paths to Discovery. These articles will emerge quarterly as an interview with someone who has led a significant advance or made a significant discovery in cardiovascular medicine or science. We will explore events that led to the advance, including the challenges, pitfalls, joys, sorrows, and eureka moments. In many instances, I believe we will see that success was far from guaranteed and, indeed, that failure was a real possibility. We will also explore what transpired after the breakthrough emerged. John Rutherford, who is leading this initiative, will be reaching out to physicians and scientists, as well as leaders in government, regulatory bodies, and industry. The scope will be international. We are hopeful that this content will be inspirational, especially to early career professionals, who sometimes believe that the path to success of our most venerated leaders has been a simple, monotonic ascent to greatness. We will all learn from these stories, many of which are overdue for telling.
Global Leadership of the Journal
We are reformulating our editorial leadership profile to have a truly global footprint. There will be creative input and decision-making authority distributed literally around the world. Our goal is to have approximately one-third of the associate editors based in Dallas, one-third elsewhere in the United States, and one-third outside the United States. I am pleased to announce that we already have recruited 4 associate editors in Europe, 3 in Asia, 1 in Africa, and 1 in South America. More are to come. Each of these leaders will have the same authority and opportunity for creative contribution as those living in Dallas. Our intent is to ensure that we speak to—and for—cardiovascular professionals around the world. Each of these editors is being charged with helping to ensure that we meet the needs of professionals in their area of expertise and in their area of the world. In other words, each of our editors will represent his/her corner of the profession and corner of the globe. Importantly, this is not a unidirectional charge; rather, these editors will also serve as emissaries for the journal, functioning as ambassadors to canvas their professional/geographic “neck of the woods.” We seek to be uniquely responsive and nimble on a global scale, contributing to the future of cardiovascular medicine around the world.
State of the Art
This section of the journal will include review articles of various types. In Depth Reviews will focus on topics of contemporary interest to the cardiovascular clinician and scientist. These are designed to provide a comprehensive and definitive review of a timely topic of high relevance to the cardiovascular community. Overviews of disease mechanisms, natural history, epidemiology, diagnostic strategies, and treatment approaches will be included in this series.
The Primer series will provide a focused review of an important area that can be covered adequately in a relatively succinct format compared with an In Depth Review.
New Drugs and Devices is a series that will provide a timely and in-depth review of new diagnostic or treatment modalities for cardiovascular disease and will include reviews of medications, biologics, and devices. Newly approved therapies will be highlighted, in particular, in this series.
Consensus Reports will be articles commissioned by the editors from a group of thought leaders to inform our readership on topics for which the evidence base is incomplete or controversial. These reports are intended to reflect a committee’s consensus after deliberations and include findings, conclusions, and recommendations based on available scientific evidence. Information in these articles is expected to include expert opinion on topics for which robust data are lacking.
White Papers will be authoritative reports that inform readers about a complex issue and present the authors’ philosophy on the matter, supported by available evidence and expert opinion. They may suggest a new framework or paradigm for thinking about a topic or disease entity and are intended to help readers understand a complex issue, solve a problem, or make a decision.
In summary, we will host a wide range of review article formats with varying scope and treatment detail. We welcome your ideas for relevant topics and invite you to submit them going forward (firstname.lastname@example.org).
We have many more initiatives in the works. Next month, I will provide another glimpse of things to come.
- © 2016 American Heart Association, Inc.